Three Scientific Posters for You


15th Annual WRIB Meeting Recap on Immunogenicity

Have a look at these three scientific posters that were presented by our scientific experts at the 15th WRIB (Workshops on Recent Issues in Bioanalysis):

Dual Purpose of a Cell-Based Assay for an Agonist of the GLP-2 Receptor 
During drug development, cell-based assays are used for multiple purposes. These include early proof of concept to identify a drug product’s pharmacological activity, and further studies to determine whether neutralizing anti-drug antibodies (NAbs) are present.
Read more.

Development of an Oligonucleotide Drug Immunogenicity Assay: a Case for the Characterization of the Immune Response 
While the immunogenicity of protein-based biologics and the characteristics of the antibody responses directed against them are well understood, the same is not true for other categories of biologics.
Read more.

Using Anti-Drug-Antibody Screening Assay to Resolve Selectivity Issues in Toxicokinetic Ligand-Binding Assay
Selectivity evaluation for regulatory toxicokinetic (TK) quantitative ligand binding assays (LBAs) is required to meet accuracy requirements for at least 80% of the individual selectivity matrix lots.
Read more.

Through different techniques, our experts will help you determine the best possible approach for your molecule, and select the optimal platform to produce high-quality results. Book a consult with one of our experts to discuss how we can support your program.

You may also be interested in the following:

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.